Ian Hagemann

Missouri

Featured in: Favicon

nature.com Favicon

tandfonline.com Favicon

onclive.com Favicon

archivesofpathology.org Favicon

onlinelibrary.wiley.com

Articles

Making a Differential Diagnosis of Low-Grade Serous Ovarian Cancer

Nov 3, 2023 | onclive.com | Ian Hagemann

Expert oncologist Ian Hagemann, MD, PhD, shares insight into the process of making a differential diagnosis of low-grade serous ovarian cancer in light of adjacent disease and available IHC testing.
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival - Communications Biology

Jul 3, 2023 | nature.com | Tiandao Li |Jin Zhang |Ian Hagemann |Gregory D. Longmore |Elaine R. Mardis |Christopher A. Maher | +3 more

AbstractHigh-grade serous ovarian cancer (HGSC) is the most lethal histotype of ovarian cancer and the majority of cases present with metastasis and late-stage disease. Over the last few decades, the overall survival for patients has not significantly improved, and there are limited targeted treatment options. We aimed to better characterize the distinctions between primary and metastatic tumors based on short- or long-term survival.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →